Does Rallies show 13F holders for THC?

Yes. Rallies tracks hedge fund and 13F ownership data for THC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is THC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.

THC (Tenet Healthcare Corporation New) Stock Analysis - Hedge Fund Holdings

Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of May 20, 2026, THC trades at $185.73 with a market cap of $16.58B and a P/E ratio of 12.05. THC moved -1.88% today. Year to date, THC is -9.47%; over the trailing twelve months it is +11.12%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $248.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns THC stock?

Hedge funds tracked by Rallies that own THC include Glenview Capital, Orbimed Advisors, Farallon Capital, DME Capital, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tenet Healthcare Corporation New.

THC Key Metrics

Key financial metrics for THC
Metric	Value
Price	$185.73
Market Cap	$16.58B
P/E Ratio	12.05
EPS	$15.61
Dividend Yield	0.00%
52-Week High	$247.21
52-Week Low	$109.82
Volume	1.58M
Avg Volume	0
Revenue (TTM)	$21.31B
Net Income	$2.37B
Gross Margin	0.00%

Top Hedge Funds Holding THC

Glenview Capital holds 1.52M shares of THC, changed -23.13% as of Mar 31, 2026.
Orbimed Advisors holds 465.00K shares of THC, changed +0.00% as of Jun 30, 2025.
Farallon Capital holds 452.15K shares of THC, changed +21.50% as of Mar 31, 2026.
DME Capital holds 287.10K shares of THC, changed -51.96% as of Sep 30, 2024.
Panagora Asset holds 189.36K shares of THC, changed +1.34% as of Mar 31, 2026.

Latest THC News

Tenet Healthcare jumps as Q1 EPS beat and reaffirmed 2026 outlook drive follow-through bid — May 6, 2026
Tenet Healthcare slips as Q1 revenue miss and softer 2026 sales outlook overshadow EPS beat — May 4, 2026
Tenet Healthcare jumps as Q1 profit beats expectations, USPI strength offsets revenue headwinds — May 1, 2026
Tenet Healthcare slips despite Q1 EPS beat as one-time CommonSpirit boost dominates — Apr 30, 2026
Tenet Reports 73% Net Income Surge to $702M, Free Cash Flow at $978M — Apr 30, 2026

Recent THC Insider Trades

Arbour Paola M sold 6.50K (~$1.55M) on Mar 11, 2026.
Arnst Thomas W sold 4.71K (~$1.12M) on Mar 9, 2026.
Arnst Thomas W sold 3.29K (~$786.87K) on Mar 9, 2026.

THC Analyst Consensus

15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $248.27.

Common questions about THC

Who owns THC stock?: Hedge funds tracked by Rallies that own THC include Glenview Capital, Orbimed Advisors, Farallon Capital, DME Capital, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tenet Healthcare Corporation New.
Does Rallies show 13F holders for THC?: Yes. Rallies tracks hedge fund and 13F ownership data for THC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is THC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.